EXTON,
Pa., May 12, 2022 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today the appointment of West's Chief Financial Officer (CFO)
Bernard J. Birkett to a newly
combined position of Chief Financial and Operations Officer. In
this expanded role, Mr. Birkett will lead our Global Operations and
Global Supply Chain. The Company's Senior Vice President, Chief
Global Operations and Supply Chain Officer, David Montecalvo has announced his resignation
to pursue other interests with a departure of July 2022 to ensure a seamless transition.
The Company also announced that West's Senior Vice President,
Global Markets and Commercial Solutions, Cindy Reiss-Clark has been appointed to the role
of Chief Commercial Officer. Additionally, West's Senior Vice
President, Commercial Products and Emerging Markets, Chris Ryan has been appointed to Senior Vice
President, Containment and Glass Systems. The Company also
announced the hiring of Kathy dePadua as Vice President and Chief
Quality Officer. Ms. dePadua joins West from GE Healthcare where
she most recently held the position of Global Quality Executive for
the Life Care Solutions Strategic business unit. She brings a
wealth of experience to the company having served in various
Quality and Regulatory leadership positions over the last 30 years
in the medical device and pharma industry.
"I am pleased to announce the appointments of Bernard, Cindy and
Chris to these new executive leadership roles, and I am extremely
pleased to welcome Kathy to the West team as we continue to advance
the importance of our purpose as a global leader in integrated
containment and delivery of injectable medicines," said
Eric M. Green, President and Chief
Executive Officer, West. "We sincerely appreciate David's
leadership and contributions to the growth and success of West over
the past six years and wish him well in his future endeavors. With
the strength of our Global Operations team, I am confident as we
seamlessly transition to Bernard's leadership, our Company is well
positioned for future growth."
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With
approximately 10,000 team members across 50 sites worldwide, West
helps support our customers by delivering over 45 billion
components and devices each year.
Headquartered in Exton,
Pennsylvania, and in business for nearly a century, West in
its fiscal year 2021 generated $2.83
billion in net sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard & Poor's
500 index. For more information, visit www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or
its subsidiaries, in the United States and other
jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/west-announces-executive-leadership-appointments-301546531.html
SOURCE West Pharmaceutical Services, Inc.